Large South African Study Shows Challenges Of Treatment As Prevention

Science: Large study spotlights limits of HIV treatment as prevention
“One of the great unknowns in HIV/AIDS research is how much prevention bang you get for your treatment buck. Yes, antiretroviral (ARV) drugs make individuals less infectious, but how many people have to be on treatment to slow spread in a community and even bring epidemics to an end? A giant new study in South Africa failed to show any reduction in HIV transmission in communities even when nearly 50 percent of infected people received the drugs…” (Cohen, 7/25).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.